A Study to Observe Treatment Patterns and Outcomes in Participants in Saudi Arabia With Human Epidermal Growth Factor Receptor 2 (HER2-Positive) Unresectable Locally Advanced or Metastatic Breast Cancer (LA/mBC)

NCT02611310 · clinicaltrials.gov ↗
TERMINATED
Status
15
Enrollment
INDUSTRY
Sponsor class

Stopped Recruitment Target not met

Conditions

Interventions

Sponsor

Hoffmann-La Roche